```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.3:c.88G>C",
                    "cDNA Change": {
                        "transcript": "NM_000345.3",
                        "ref": "G",
                        "alt": "C",
                        "position": "88"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P"
                },
                {
                    "HGVS": "NM_000345.3:c.157G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "157"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Microarray Analysis",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "BE2-M17",
                "Description": "Stable human neuronal cell lines (BE2-M17) over-expressing wild-type or mutant human a-synuclein."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.88G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "A30P variant showed altered expression of several genes, including those involved in dopamine synthesis."
                },
                {
                    "Variant": "NM_000345.3:c.157G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "A53T variant showed altered expression of several genes, including those involved in dopamine synthesis."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Four clonal cell lines overexpressing either wild-type or A53T a-synuclein were used."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Vector-only cell line used as a control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Pairwise comparisons with the vector-only cell line were carried out to give fold change levels of expression."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Expression levels within ± 2.0 fold change compared to vector-only control.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Expression levels greater than ± 2.0 fold change compared to vector-only control.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Quantitative RT-PCR",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "BE2-M17",
                "Description": "Stable human neuronal cell lines (BE2-M17) over-expressing wild-type or mutant human a-synuclein."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.88G>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Confirmed altered expression of genes in dopamine synthesis pathway for A30P variant."
                },
                {
                    "Variant": "NM_000345.3:c.157G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Confirmed altered expression of genes in dopamine synthesis pathway for A53T variant."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Seven clones over-expressing a-synuclein were used."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "At least eight replicate measurements were made for each gene."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Vector-only cell line used as a control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Expression levels for each gene were calculated for four simultaneous reactions and confirmed on at least two separate reaction plates."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Expression levels similar to vector-only control.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Expression levels significantly different from vector-only control.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```